NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

Conditions: Hypertrophic Cardiomyopathy; Left Ventricular Septal Hypertrophy; Mitral Valve Disease; Aortic Valve Stenosis
Interventions: Device: Septal Scoring Along Midline Endocardium
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 22, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments